Search results
Order by most recent / most popular / relevance
Results: 1-10 of 19
Universities abroad experiment with no-fee licensing to drive biotech partnerships
- Shook Hardy & Bacon LLP
- -
- Australia, Canada, European Union, United Kingdom, USA
- -
- May 16 2013
Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies
EU Medicines Agency plans to appeal interim rulings on release of clinical trial data
- Shook Hardy & Bacon LLP
- -
- European Union
- -
- May 16 2013
According to a news source, European Medicines Agency (EMA) Director Guido Rasi intends to appeal interim rulings recently issued by the European
EU regulators charge pharma companies with antitrust violations in pay-for-delay deals
- Shook Hardy & Bacon LLP
- -
- European Union
- -
- August 2 2012
The European Commission (EC) has reportedly charged nine pharmaceutical companies with breaches of European Union (EU) antitrust rules for entering pay-for-delay deals with generic competitors
News bytes
- Shook Hardy & Bacon LLP
- -
- European Union, USA
- -
- December 16 2010
The European Medicines Agency (EMA) adopts two draft guidelines as part of the regulatory approval process for certain biosimilar medicinal products
EU Court of Justice nixes patents for stem-cell inventions involving human embryo destruction
- Shook Hardy & Bacon LLP
- -
- European Union
- -
- October 20 2011
The European Union (EU) Court of Justice has determined that EU patent law does not protect neural precursor cells and the processes for their production from embryonic stem cells
Wellcome Trust creates £200-million fund for UK, EU biotech startups
- Shook Hardy & Bacon LLP
- -
- European Union, United Kingdom
- -
- March 29 2012
The U.K.-based Wellcome Trust has announced the creation of a £200-million fund to make long-term investments in British and European biotechnology startups
Researchers protest ECJ advocate general’s position on patenting stem cell technologies
- Shook Hardy & Bacon LLP
- -
- European Union
- -
- May 5 2011
Viewing the issue as a matter of morality, the advocate general of the European Court of Justice (ECJ) recently delivered a non-binding ruling that would render unpatentable the cells removed from the human embryo at the blastocyst stage, because the removal involves the embryo's destruction
Joint public meeting to focus on bridging nanotechnology research
- Shook Hardy & Bacon LLP
- -
- European Union, USA
- -
- February 24 2011
The National Nanotechnology Coordination Office has announced that it will spearhead a public meeting to focus on "environmental health and safety questions for nanomaterials and nanotechnology-enabled products" and to "encourage joint US-EU programs of work that would leverage resources."
EU legal services opinion could upset proposed GM laws
- Shook Hardy & Bacon LLP
- -
- European Union
- -
- November 18 2010
According to media sources, the EU Council of Ministers' Legal Service has expressed "strong doubts" about the feasibility of a proposal that would allow individual member states to set their own policies for regulating genetically modified (GM) crops
Report suggests Europe could become marine biotech leader by 2020
- Shook Hardy & Bacon LLP
- -
- European Union
- -
- January 13 2011
The Marine Board of the European Science Foundation has released a report that suggests Europe could become a global leader in marine biotechnology by 2020, particularly by cultivating microalgae for fuel
Current Search
- Workarea - Healthcare
- Jurisdiction - European Union
- Author - Thomas T. Moga
Suggested Facets
Author
- Chris A. Johnson (13)
- Debra S. Dunne (2)
- John D. Garretson (8)
- Madeleine McDonough (19)
- Patrick Henderson (19)